The Gold Standard Disintegrant for Pharmaceutical Excellence
Sodium Starch Glycolate USP/NF stands as the most widely used and trusted disintegrant in pharmaceutical manufacturing, serving as the cornerstone of tablet formulation and solid dosage form development worldwide. This essential pharmaceutical excipient combines exceptional disintegration properties, superior swelling capacity, and proven manufacturing performance that make it indispensable for immediate-release tablets, orally disintegrating tablets, capsule formulations, and specialty pharmaceutical applications. The global pharmaceutical excipients market, valued at USD 8.9 billion in 2024, is expected to reach USD 13.8 billion by 2034, exhibiting a CAGR of 4.5% during the forecast period, with disintegrants representing approximately 15% of the total market, driven by expanding generic drug manufacturing, increasing oral solid dosage production, and growing demand for patient-friendly formulations.
Sodium starch glycolate’s unique molecular structure, featuring cross-linked starch chains with carboxymethyl and carboxylate groups, confers remarkable water uptake properties, excellent swelling characteristics, and superior disintegration performance that make it ideal for ensuring rapid tablet breakdown, enhanced drug dissolution, and improved bioavailability. This combination of properties positions sodium starch glycolate as an irreplaceable component in pharmaceutical formulations where disintegration speed, manufacturing efficiency, and patient compliance are paramount.
The oral solid dosage forms segment represents the largest application area for sodium starch glycolate, accounting for approximately 85% of total consumption, followed by orally disintegrating tablets at 10%, and specialized pharmaceutical applications at 5%. This distribution reflects sodium starch glycolate’s fundamental importance in modern pharmaceutical manufacturing and patient care.
Chemical Properties & Technical Specifications
| Property | Specification |
|---|---|
| Chemical Name | Sodium Starch Glycolate |
| Chemical Formula | Variable (modified starch) |
| CAS Number | 9063-38-1 |
| Molecular Weight | Variable (polymer) |
| Physical State | White to off-white powder |
| Odor | Odorless or slight characteristic odor |
| Taste | Tasteless |
| Particle Size | 30-100 mesh (USP) |
| Bulk Density | 0.4-0.8 g/mL |
| Tapped Density | 0.6-1.0 g/mL |
| Carr’s Index | 15-25% |
| Hausner Ratio | 1.2-1.3 |
| Angle of Repose | 25-40° |
| Moisture Content | ≤10% (USP) |
| pH | 6.0-8.0 (1% suspension) |
| Solubility | Insoluble in water, swells rapidly |
| Swelling Capacity | 300-800% (varies by grade) |
| Disintegration Time | <15 seconds (tablet test) |
| Microbial Limits | USP compliant |
| Heavy Metals | ≤20 ppm |
| Lead | ≤5 ppm |
| Mercury | ≤1 ppm |
| Cadmium | ≤1 ppm |
| Arsenic | ≤3 ppm |
| Loss on Drying | ≤10% |
| Sulfated Ash | ≤7% |
| Sodium Content | 2.8-4.2% |
| Chloride Content | ≤0.35% |
| Starch Content | ≥85% |
Sodium Starch Glycolate Grades & Specifications
USP/NF Grade
- Compliance: USP/NF monograph specifications
- Applications: Pharmaceutical tablets and capsules
- Purity: Pharmaceutical manufacturing standards
- Quality: Consistent batch-to-batch performance
EP Grade (European Pharmacopoeia)
- Compliance: EP monograph specifications
- Applications: European pharmaceutical markets
- Quality: European regulatory standards
- Documentation: Complete EP compliance package
JP Grade (Japanese Pharmacopoeia)
- Compliance: JP monograph specifications
- Applications: Japanese pharmaceutical markets
- Quality: Japanese regulatory standards
- Specifications: JP-specific requirements
High Swelling Grade
- Swelling Capacity: 600-800%
- Applications: Fast-disintegrating tablets
- Performance: Maximum disintegration speed
- Efficiency: Lower usage levels required
Standard Grade
- Swelling Capacity: 300-500%
- Applications: Conventional tablets
- Performance: Reliable disintegration
- Cost: Economic standard option
Fine Particle Grade
- Particle Size: 80-120 mesh
- Applications: Direct compression
- Flow: Enhanced flow properties
- Compressibility: Improved tablet hardness
Comprehensive Industry Applications
💊 Pharmaceutical Manufacturing Excellence
- Immediate-release tablets for rapid drug delivery
- Orally disintegrating tablets for patient convenience
- Capsule formulations for powder blending
- Granulation processes for tablet manufacturing
- Direct compression for efficient production
🏭 Manufacturing Process Applications
- Wet granulation for tablet production
- Dry granulation for moisture-sensitive drugs
- Direct compression for simplified manufacturing
- Coating applications for specialized formulations
- Powder blending for uniform distribution
⚡ Fast-Acting Formulations
- Rapid-release tablets for immediate effect
- Sublingual tablets for buccal absorption
- Chewable tablets for pediatric applications
- Effervescent tablets for enhanced dissolution
- Dispersible tablets for liquid dosing
🧪 Specialized Applications
- Controlled-release systems for sustained delivery
- Enteric-coated tablets for delayed release
- Floating tablets for gastric retention
- Mucoadhesive tablets for targeted delivery
- Taste-masked formulations for palatability
Pharmaceutical Manufacturing Applications
Immediate-Release Tablets
Sodium starch glycolate serves as the primary disintegrant in immediate-release tablet formulations, typically used at 2-8% concentration. Its rapid swelling properties ensure quick tablet breakdown and enhanced drug dissolution, leading to improved bioavailability and therapeutic efficacy.
Orally Disintegrating Tablets (ODTs)
ODT formulations utilize sodium starch glycolate at higher concentrations (4-12%) to achieve ultra-fast disintegration within 15-30 seconds. This enables convenient administration without water, improving patient compliance, particularly for pediatric and geriatric populations.
Capsule Formulations
Hard gelatin capsules employ sodium starch glycolate as a disintegrant and flow aid in powder and granule formulations. Its excellent flow properties facilitate uniform capsule filling and consistent drug content uniformity.
Generic Drug Manufacturing
Generic pharmaceutical manufacturers rely on sodium starch glycolate for bioequivalence studies and product development. Its consistent performance ensures reliable dissolution profiles and regulatory compliance for abbreviated new drug applications (ANDAs).
Specialty Dosage Forms
Specialized pharmaceutical applications include taste-masked formulations, pediatric medicines, and geriatric-friendly dosage forms. Sodium starch glycolate’s neutral taste and excellent compatibility make it suitable for these specialized applications.
Manufacturing Process Applications
Wet Granulation
Wet granulation processes incorporate sodium starch glycolate either intragranularly (during granulation) or extragranularly (after granulation) to optimize disintegration properties. The intragranular addition provides rapid granule breakdown, while extragranular addition offers additional disintegrating force.
Dry Granulation
Dry granulation methods, including slugging and roller compaction, utilize sodium starch glycolate to maintain disintegration properties in moisture-sensitive formulations. Its stability during compression makes it ideal for these applications.
Direct Compression
Direct compression tablet manufacturing employs sodium starch glycolate as a multifunctional excipient providing disintegration, binding, and flow properties. This simplifies manufacturing processes and reduces production costs.
Fluid Bed Granulation
Fluid bed granulation processes use sodium starch glycolate in the granulating solution or as a dry blend component. Its heat stability and processing compatibility make it suitable for these manufacturing methods.
High-Shear Granulation
High-shear granulation employs sodium starch glycolate to maintain disintegration properties during intensive mixing processes. Its mechanical stability ensures consistent performance under high-energy conditions.
Fast-Acting Formulation Applications
Rapid-Release Systems
Rapid-release formulations maximize sodium starch glycolate concentration (6-12%) to achieve immediate drug release. These formulations are particularly valuable for analgesics, antihistamines, and emergency medications.
Sublingual Tablets
Sublingual formulations utilize sodium starch glycolate to facilitate rapid tablet breakdown and drug dissolution in the oral cavity. This enables quick absorption and rapid onset of action.
Chewable Tablets
Chewable tablet formulations employ sodium starch glycolate to ensure complete disintegration after chewing. Its neutral taste and smooth texture enhance patient acceptability.
Effervescent Tablets
Effervescent formulations combine sodium starch glycolate with effervescent agents to create rapidly dissolving tablets. The disintegrant ensures complete tablet breakdown while effervescence enhances dissolution.
Dispersible Tablets
Dispersible tablet formulations use sodium starch glycolate to create uniform suspensions when mixed with water. This enables accurate dosing and improved palatability for pediatric applications.
Quality Control & Manufacturing
Raw Material Testing
Comprehensive raw material testing ensures sodium starch glycolate meets pharmacopeial specifications including particle size, moisture content, pH, and microbial limits. These tests guarantee consistent quality and performance.
In-Process Controls
Manufacturing processes implement in-process controls monitoring blend uniformity, tablet hardness, disintegration time, and dissolution performance. These controls ensure consistent product quality.
Finished Product Testing
Finished dosage forms undergo extensive testing including dissolution, content uniformity, stability, and bioavailability studies. Sodium starch glycolate’s performance is critical for meeting these specifications.
Stability Studies
Accelerated and long-term stability studies evaluate sodium starch glycolate’s performance under various storage conditions. These studies support shelf life determination and packaging recommendations.
Regulatory Compliance & Safety
Pharmacopeial Standards
Sodium starch glycolate meets all major pharmacopeial requirements including USP/NF, EP, JP, and other regional standards. This ensures global regulatory acceptance and market access.
Safety Profile
Extensive safety data demonstrates sodium starch glycolate’s excellent safety profile for oral administration. Its natural starch origin and long history of safe use support its widespread pharmaceutical application.
Regulatory Approvals
Sodium starch glycolate holds regulatory approvals from FDA, EMA, and other international agencies. These approvals enable its use in pharmaceutical products worldwide.
Quality Systems
Manufacturing facilities operate under cGMP standards ensuring consistent quality and regulatory compliance. Quality systems encompass raw material control, manufacturing processes, and finished product testing.
Market Dynamics & Growth Drivers
Generic Drug Expansion
The growing generic pharmaceutical market drives demand for cost-effective excipients like sodium starch glycolate. Generic manufacturers require reliable, economical disintegrants for competitive formulations.
Oral Solid Dosage Growth
Increasing preference for oral solid dosage forms over other delivery methods supports sodium starch glycolate demand. Patient convenience and manufacturing efficiency drive this trend.
Emerging Markets
Pharmaceutical manufacturing expansion in emerging markets creates new demand for sodium starch glycolate. These markets offer growth opportunities for excipient suppliers.
Patient-Friendly Formulations
Growing emphasis on patient-friendly formulations including ODTs and taste-masked products increases demand for specialized sodium starch glycolate grades.
Innovation & Development
Modified Grades
Research into modified sodium starch glycolate grades focuses on enhanced performance characteristics including faster disintegration, improved flow properties, and specialized applications.
Co-Processing
Development of co-processed excipients combining sodium starch glycolate with other functional ingredients creates multifunctional materials for simplified formulations.
Particle Engineering
Advanced particle engineering techniques optimize sodium starch glycolate’s physical properties for specific applications including direct compression and specialized dosage forms.
Sustainability Initiatives
Sustainability initiatives focus on renewable raw materials, reduced environmental impact, and green manufacturing processes for sodium starch glycolate production.
Supply Chain Excellence
Global Manufacturing
- Multi-regional production for supply security
- Quality standardization across facilities
- Capacity optimization for demand management
- Regulatory compliance for market access
Raw Material Sourcing
- Sustainable starch sources for reliable supply
- Quality specifications for raw materials
- Supplier qualification for consistency
- Supply chain security for continuity
Distribution Network
- Efficient logistics for timely delivery
- Quality preservation during transport
- Inventory management for availability
- Customer support for technical assistance
Technical Services
- Formulation support for optimal performance
- Analytical services for quality verification
- Regulatory assistance for compliance
- Training programs for proper use
Why Choose Our Sodium Starch Glycolate?
✅ Pharmaceutical Excellence
Full USP/NF, EP, and JP compliance ensures regulatory acceptance and product quality for pharmaceutical applications worldwide.
✅ Superior Performance
Consistent disintegration properties, excellent swelling capacity, and reliable manufacturing performance ensure optimal tablet quality.
✅ Manufacturing Efficiency
Excellent flow properties, compressibility, and processing compatibility enhance manufacturing efficiency and reduce production costs.
✅ Quality Assurance
Comprehensive quality control systems ensure consistent batch-to-batch performance and regulatory compliance.
✅ Technical Support
Expert formulation support, analytical services, and regulatory assistance ensure successful product development and manufacturing.
✅ Global Supply
Robust manufacturing capabilities and worldwide distribution network ensure reliable product availability and delivery.
